Corcept Therapeutics (CORT) stock valuation

$67.35 Nov 18, 2026 · market cap $8.1B

10/121 investors
i

Corcept Therapeutics trades at $67. Our three models put it at $24–$42 (base $24): above all three.

Damodaran $42 · Cash Flow $32 · Buffett $24 · models run Nov 18, 2026

10 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate CORTCreate free account →

Full open-source research report for CORT on DeepValues Research (CC BY 4.0)